Compare SGHC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHC | CAI |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | Guernsey | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.2B |
| IPO Year | N/A | 2025 |
| Metric | SGHC | CAI |
|---|---|---|
| Price | $10.90 | $25.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $16.00 | ★ $35.50 |
| AVG Volume (30 Days) | ★ 3.2M | 1.7M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | ★ 4925.62 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $2,342,912,011.00 | $649,062,000.00 |
| Revenue This Year | $23.47 | $64.66 |
| Revenue Next Year | $10.10 | $45.81 |
| P/E Ratio | $23.91 | ★ N/A |
| Revenue Growth | 34.94 | ★ 112.02 |
| 52 Week Low | $5.45 | $22.86 |
| 52 Week High | $14.38 | $42.50 |
| Indicator | SGHC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.80 | N/A |
| Support Level | $11.54 | N/A |
| Resistance Level | $12.49 | N/A |
| Average True Range (ATR) | 0.60 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 7.94 | 0.00 |
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.